MSCI INC (MSCI)

US55354G1004 - Common Stock

604.8  +4.22 (+0.7%)

Premarket: 604.8 0 (0%)

Fundamental Rating

6

Taking everything into account, MSCI scores 6 out of 10 in our fundamental rating. MSCI was compared to 220 industry peers in the Capital Markets industry. MSCI has an excellent profitability rating, but there are some minor concerns on its financial health. MSCI is valued quite expensively, but it does show have an excellent growth rating. This makes MSCI very considerable for growth investing!



9

1. Profitability

1.1 Basic Checks

In the past year MSCI was profitable.
MSCI had a positive operating cash flow in the past year.
In the past 5 years MSCI has always been profitable.
In the past 5 years MSCI always reported a positive cash flow from operatings.

1.2 Ratios

MSCI's Return On Assets of 22.31% is amongst the best of the industry. MSCI outperforms 99.08% of its industry peers.
MSCI has a better Return On Invested Capital (31.00%) than 98.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MSCI is significantly above the industry average of 7.00%.
The 3 year average ROIC (25.66%) for MSCI is below the current ROIC(31.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.31%
ROE N/A
ROIC 31%
ROA(3y)17.14%
ROA(5y)15.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)25.66%
ROIC(5y)23.88%

1.3 Margins

MSCI's Profit Margin of 43.06% is amongst the best of the industry. MSCI outperforms 86.18% of its industry peers.
MSCI's Profit Margin has improved in the last couple of years.
MSCI's Operating Margin of 53.31% is amongst the best of the industry. MSCI outperforms 88.48% of its industry peers.
MSCI's Operating Margin has improved in the last couple of years.
MSCI has a better Gross Margin (81.97%) than 83.41% of its industry peers.
MSCI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 53.31%
PM (TTM) 43.06%
GM 81.97%
OM growth 3Y1.61%
OM growth 5Y2.71%
PM growth 3Y8.56%
PM growth 5Y5.1%
GM growth 3Y-0.18%
GM growth 5Y0.59%

5

2. Health

2.1 Basic Checks

The number of shares outstanding for MSCI has been reduced compared to 1 year ago.
MSCI has less shares outstanding than it did 5 years ago.
MSCI has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 7.22 indicates that MSCI is not in any danger for bankruptcy at the moment.
MSCI has a Altman-Z score of 7.22. This is amongst the best in the industry. MSCI outperforms 93.09% of its industry peers.
MSCI has a debt to FCF ratio of 3.30. This is a good value and a sign of high solvency as MSCI would need 3.30 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.30, MSCI is doing good in the industry, outperforming 72.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.3
Altman-Z 7.22
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.93 indicates that MSCI may have some problems paying its short term obligations.
With a Current ratio value of 0.93, MSCI perfoms like the industry average, outperforming 43.32% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that MSCI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, MSCI is in line with its industry, outperforming 43.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93

7

3. Growth

3.1 Past

MSCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.84%, which is quite good.
The Earnings Per Share has been growing by 20.75% on average over the past years. This is a very strong growth
MSCI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.05%.
MSCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.02% yearly.
EPS 1Y (TTM)15.84%
EPS 3Y20%
EPS 5Y20.75%
EPS Q2Q%11.88%
Revenue 1Y (TTM)16.05%
Revenue growth 3Y14.26%
Revenue growth 5Y12.02%
Sales Q2Q%15.87%

3.2 Future

Based on estimates for the next years, MSCI will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.11% on average per year.
MSCI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.83% yearly.
EPS Next Y13.06%
EPS Next 2Y13.36%
EPS Next 3Y13.37%
EPS Next 5Y13.11%
Revenue Next Year14.39%
Revenue Next 2Y11.83%
Revenue Next 3Y11%
Revenue Next 5Y9.83%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.14 indicates a quite expensive valuation of MSCI.
78.80% of the companies in the same industry are cheaper than MSCI, based on the Price/Earnings ratio.
MSCI is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 34.79, which means the current valuation is very expensive for MSCI.
Based on the Price/Forward Earnings ratio, MSCI is valued a bit more expensive than the industry average as 76.04% of the companies are valued more cheaply.
MSCI is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.14
Fwd PE 34.79

4.2 Price Multiples

MSCI's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as MSCI.
Industry RankSector Rank
P/FCF 34.88
EV/EBITDA 30.77

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MSCI may justify a higher PE ratio.
A more expensive valuation may be justified as MSCI's earnings are expected to grow with 13.37% in the coming years.
PEG (NY)3.15
PEG (5Y)1.98
EPS Next 2Y13.36%
EPS Next 3Y13.37%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.07%, MSCI has a reasonable but not impressive dividend return.
MSCI's Dividend Yield is slightly below the industry average, which is at 9.57.
Compared to an average S&P500 Dividend Yield of 2.36, MSCI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

On average, the dividend of MSCI grows each year by 23.10%, which is quite nice.
MSCI has paid a dividend for at least 10 years, which is a reliable track record.
MSCI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)23.1%
Div Incr Years10
Div Non Decr Years10

5.3 Sustainability

40.88% of the earnings are spent on dividend by MSCI. This is a bit on the high side, but may be sustainable.
The dividend of MSCI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.88%
EPS Next 2Y13.36%
EPS Next 3Y13.37%

MSCI INC

NYSE:MSCI (12/20/2024, 8:25:41 PM)

Premarket: 604.8 0 (0%)

604.8

+4.22 (+0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)01-28 2025-01-28/amc
Inst Owners93.57%
Inst Owner Change-2.09%
Ins Owners2.8%
Ins Owner Change-0.04%
Market Cap47.40B
Analysts75
Price Target659.43 (9.03%)
Short Float %0.96%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Dividend Growth(5Y)23.1%
DP40.88%
Div Incr Years10
Div Non Decr Years10
Ex-Date11-15 2024-11-15 (1.6)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.47%
Min EPS beat(2)0.37%
Max EPS beat(2)0.58%
EPS beat(4)4
Avg EPS beat(4)2.68%
Min EPS beat(4)0.1%
Max EPS beat(4)9.66%
EPS beat(8)8
Avg EPS beat(8)2.4%
EPS beat(12)11
Avg EPS beat(12)2.26%
EPS beat(16)14
Avg EPS beat(16)2.49%
Revenue beat(2)0
Avg Revenue beat(2)-0.53%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.34%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)2.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.67%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)3
Avg Revenue beat(16)-0.95%
PT rev (1m)0.53%
PT rev (3m)9.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.82%
EPS NY rev (1m)0.1%
EPS NY rev (3m)1.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.57%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 41.14
Fwd PE 34.79
P/S 16.91
P/FCF 34.88
P/OCF 32.47
P/B N/A
P/tB N/A
EV/EBITDA 30.77
EPS(TTM)14.7
EY2.43%
EPS(NY)17.39
Fwd EY2.87%
FCF(TTM)17.34
FCFY2.87%
OCF(TTM)18.63
OCFY3.08%
SpS35.76
BVpS-9.58
TBVpS-58.68
PEG (NY)3.15
PEG (5Y)1.98
Profitability
Industry RankSector Rank
ROA 22.31%
ROE N/A
ROCE 37.06%
ROIC 31%
ROICexc 35.4%
ROICexgc N/A
OM 53.31%
PM (TTM) 43.06%
GM 81.97%
FCFM 48.49%
ROA(3y)17.14%
ROA(5y)15.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)25.66%
ROIC(5y)23.88%
ROICexc(3y)33.68%
ROICexc(5y)35.13%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)30.68%
ROCE(5y)28.55%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-0.96%
OM growth 3Y1.61%
OM growth 5Y2.71%
PM growth 3Y8.56%
PM growth 5Y5.1%
GM growth 3Y-0.18%
GM growth 5Y0.59%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.3
Debt/EBITDA 2.69
Cap/Depr 57.4%
Cap/Sales 3.6%
Interest Coverage 8.2
Cash Conversion 87.42%
Profit Quality 112.59%
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 7.22
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)61.34%
Cap/Depr(5y)62.12%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.25%
Profit Quality(3y)112.59%
Profit Quality(5y)116.08%
High Growth Momentum
Growth
EPS 1Y (TTM)15.84%
EPS 3Y20%
EPS 5Y20.75%
EPS Q2Q%11.88%
EPS Next Y13.06%
EPS Next 2Y13.36%
EPS Next 3Y13.37%
EPS Next 5Y13.11%
Revenue 1Y (TTM)16.05%
Revenue growth 3Y14.26%
Revenue growth 5Y12.02%
Sales Q2Q%15.87%
Revenue Next Year14.39%
Revenue Next 2Y11.83%
Revenue Next 3Y11%
Revenue Next 5Y9.83%
EBIT growth 1Y12.96%
EBIT growth 3Y16.1%
EBIT growth 5Y15.05%
EBIT Next Year24.02%
EBIT Next 3Y14.79%
EBIT Next 5Y12.94%
FCF growth 1Y38.24%
FCF growth 3Y14.64%
FCF growth 5Y15.23%
OCF growth 1Y37.78%
OCF growth 3Y15.08%
OCF growth 5Y15.06%